Unfortunately downward pressure seems to be increasing lately. Maybe people had stop losses set at $1 let’s hope it’s that and not something else we are missing. This company is fortunate to have more than a few faithful longs, they need to start paying back with revenue transparency. I don’t want to see one more article about a new lab acquisition, favorable new laws in different states, or a venture into a new space (like clinical develpment which is expensive and long term) until I see monetization of existing assets at high margins. I don’t think I’m asking too much here.